Riverbridge Partners’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Riverbridge Partners’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,361,659	Closed	-$48M	–	136
2015 Q1	$48M	Buy	1,361,659 +2,795	+0.2%	+$94.6K	0.86%	44
2014 Q4	$43.7M	Sell	1,358,864 -84,347	-6%	-$2.44M	0.81%	46
2014 Q3	$40.5M	Sell	1,443,211 -231,179	-14%	-$7.04M	0.79%	49
2014 Q2	$50.6M	Sell	1,674,390 -387,900	-19%	-$10.7M	0.88%	44
2014 Q1	$57.1M	Sell	2,062,290 -10,610	-0.5%	-$278K	1.03%	37
2013 Q4	$52.9M	Buy	2,072,900 +264,659	+15%	+$8.16M	0.96%	39
2013 Q3	$54M	Buy	1,808,241 +33,212	+2%	+$924K	1.17%	35
2013 Q2	$51M	Buy	+1,775,029	New	+$48.9M	1.27%	29

Other funds holding BRLI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Riverbridge Partners's BRLI Position: Q2 2015 in Review

Riverbridge Partners sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q2 2015, closing a stake of 1,361,659 shares — an estimated $48M sold.

Riverbridge Partners first reported a position in BRLI in Q2 2013 and held it in 8 quarters. The position peaked at $57.1M in Q1 2014. 183 funds tracked by Wall St. Rank hold BRLI as of Q2 2015.

Riverbridge Partners reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q2 2015 after selling out during the quarter.
Riverbridge Partners sold 1,361,659 BIO-REFERENCE LABS INC-NEW- shares in Q2 2015, an estimated $48M.
Riverbridge Partners first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 8 quarters.
Riverbridge Partners's BIO-REFERENCE LABS INC-NEW- position peaked at $57.1M in Q1 2014.
183 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q2 2015.

Based on Riverbridge Partners's 13F filing for Q2 2015, filed 20 Jul 2015.